Related Experiment Video
Updated: Jun 30, 2026

06:53
Rapid Antibody Glycoengineering in Chinese Hamster Ovary Cells
Published on: June 2, 2022
Decrease in antithrombin III fucosylation by expressing GDP-fucose transporter siRNA in Chinese hamster ovary cells
Takeshi Omasa1, Ryo Tanaka, Tomohiro Doi
1Department of Biotechnology, Graduate School of Engineering, Osaka University, Suita, Osaka, Japan. omasa@bio.eng.osaka-u.ac.jp
Journal of Bioscience and Bioengineering
|September 23, 2008
Summary
Researchers cloned GDP-fucose transporter (GFT) from CHO cells. Inhibiting GFT with siRNA increased defucosylated antithrombin III (AT-III) by up to 40% in recombinant cells.
Area of Science:
- Biotechnology
- Molecular Biology
- Cell Biology
Background:
- GDP-fucose transporter (GFT) is crucial for fucose incorporation into glycoproteins.
- Defucosylation of recombinant proteins can impact their efficacy and immunogenicity.
- Chinese hamster ovary (CHO) cells are widely used for recombinant protein production.
Purpose of the Study:
- To clone and characterize the GDP-fucose transporter (GFT) from Chinese hamster ovary (CHO) cells.
- To investigate the effect of GFT inhibition on the fucosylation of recombinant human antithrombin III (AT-III).
Main Methods:
- Cloning of full-length GFT cDNA from CHO cells.
- Synthesis and application of small interfering RNA (siRNA) targeting CHO GFT.
- Construction of a GFT siRNA expression plasmid for cell transfection.
- Analysis of defucosylated AT-III levels and Golgi-GDP fucose reduction.
Main Results:
- The cloned GFT exhibited high similarity to human and mouse GFT.
- siRNA-mediated GFT inhibition in recombinant CHO cells led to a 30-40% increase in defucosylated AT-III.
- Transfection with a GFT siRNA expression plasmid reduced Golgi-GDP fucose by approximately 75% and increased defucosylated AT-III by 10-40%.
Conclusions:
- The cloned GFT is a functional transporter in CHO cells.
- Targeting GFT effectively reduces protein fucosylation in recombinant CHO cells.
- This approach offers a strategy to enhance the production of defucosylated recombinant proteins like AT-III.
